– UK, London – Unilever PLC (LON: ULVR | NYSE: UN) today announced the appointment of Ruby Lu to its Board as a Non-Executive Director, effective from 1 November 2021.
“I am very pleased that Ruby has agreed to join the Board. She has had a successful executive career, and will further strengthen the Board with her extensive financial and global market experience”, said Board Chairman, Nils Andersen.
Ruby will also join both the Compensation Committee and the Nominating and Corporate Governance Committee.
About Ruby Lu
Ruby Lu is a venture capitalist investing in technology start-ups in the U.S. and China. Ruby founded Atypical Ventures, an early-stage technology venture investment firm, in 2019. In 2006, she co-founded DCM China, a venture capital firm. During her more than 12-year tenure at DCM, she invested in, and served as a board member for, many leading technology companies. Prior to joining DCM in 2003, Ruby was VP in the investment banking group of technology, media and telecommunications at Goldman Sachs & Co.
Ruby is currently a Non-Executive Director at Uxin Limited and Yum China. Within the last five years, Ruby has been a Non-Executive Director at two other companies which were publicly quoted during such time: Blue City Holdings Limited and Ikang Healthcare Group.
Unilever PLC is a British multinational consumer goods company headquartered in London, England. Unilever products include food, condiments, ice cream, wellbeing vitamins, minerals and supplements, tea, coffee, breakfast cereal, cleaning agents, water and air purifiers, pet food, toothpaste, beauty products, and personal care. Unilever is the largest producer of soap in the world. Unilever’s products are available in around 190 countries.
For more information : https://www.unilever.com
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.